Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Updates Rating on Array Technologies to Neutral

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_Banking (2)
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Mizuho analyst Maheep Mandloi updated their rating on Array Technologies (NASDAQ: ARRY) to Neutral and decreased the price target to $18 from $20. This change in perspective differs from their previous report, where Mandloi had maintained a Neutral rating but raised the price target to $20 from $19. The revised price target suggests a shift in the analyst’s view on the company’s performance. This adjustment comes after Mizuho first covered Array Technologies with a Neutral recommendation in November 2023. In contrast, Mizuho reaffirmed a Buy recommendation for Qualcomm (NASDAQ: QCOM) in August 2023.

ARRY Stock Price Rises 1.79% on February 28, 2024: Investors Cautiously Optimistic

On February 28, 2024, ARRY stock closed at $13.64, marking a $0.24 increase since the previous market close, a 1.79% rise for the day. Despite this increase, ARRY is still trading near the bottom of its 52-week range and below its 200-day simple moving average.

The stock did not experience any significant movement in after-hours trading, remaining unchanged. This stability could indicate that investors are cautiously optimistic about the stock’s performance in the near future.

Investors should continue to monitor the stock’s performance and consider any relevant news or events that may impact its price movement. Overall, the slight uptick in ARRY’s stock price on February 28, 2024, suggests some positive momentum for the company. However, investors should exercise caution and conduct thorough research before making any investment decisions related to ARRY or any other stock.

ARRY Stock Financial Performance: Revenue Decline but Strong Net Income Growth – February 28, 2024 Analysis

On February 28, 2024, ARRY stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $1.58 billion for the past year, which decreased by 3.72% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $341.62 million for Q4.

In terms of net income, ARRY reported a significant increase of 2996.57% since the previous year, with a net income of $137.24 million for the past year. The net income also held flat since the last quarter, with $19.34 million reported for Q4.

Earnings per share (EPS) for ARRY stock showed a positive trend over the past year, with an increase of 292.31% compared to the previous year. The EPS stood at $0.56 for the past year but decreased by 40.6% since the last quarter, with an EPS of $0.04 for Q4.

Overall, ARRY stock showed strong growth in net income and earnings per share over the past year. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: ARRY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
AI medical laboratory

Crinetics Pharmaceuticals Secures 350 Million in Private Placement Financing

DrugRetailers Trading online

Vipshops Impressive Q4 Results Drive Surge in Stock Value

Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Anticipating Evergys Financial Results A Look at Past Performance and Future Projections

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com